Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia
Latest Information Update: 21 Mar 2024
At a glance
- Drugs Macimorelin (Primary)
- Indications Cachexia
- Focus Therapeutic Use
- 02 Aug 2022 Status changed from active, no longer recruiting to completed.
- 29 Jan 2021 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 03 Jan 2020 Planned primary completion date changed from 1 Jul 2019 to 1 Jul 2020.